Meeder Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-267
| Closed | -$27.2K | – | 602 |
|
|
2023
Q2 | $27.2K | Buy |
+267
| New | +$27.2K | ﹤0.01% | 419 |
|
|
2021
Q4 | – | Sell |
-11
| Closed | -$1K | – | 2486 |
|
|
2021
Q3 | $1K | Hold |
11
| – | – | ﹤0.01% | 2409 |
|
|
2021
Q2 | $2K | Hold |
11
| – | – | ﹤0.01% | 2273 |
|
|
2021
Q1 | $1K | Hold |
11
| – | – | ﹤0.01% | 2289 |
|
|
2020
Q4 | $1K | Hold |
11
| – | – | ﹤0.01% | 1778 |
|
|
2020
Q3 | $1K | Sell |
11
-35
| -76% | -$3.18K | ﹤0.01% | 2079 |
|
|
2020
Q2 | $7K | Sell |
46
-4
| -8% | -$609 | ﹤0.01% | 1447 |
|
|
2020
Q1 | $7K | Sell |
50
-890
| -95% | -$125K | ﹤0.01% | 1679 |
|
|
2019
Q4 | $193K | Buy |
+940
| New | +$193K | 0.01% | 612 |
|
|
2019
Q3 | – | Sell |
-360
| Closed | -$34K | – | 2301 |
|
|
2019
Q2 | $34K | Sell |
360
-440
| -55% | -$41.6K | ﹤0.01% | 1063 |
|
|
2019
Q1 | $69K | Sell |
800
-669
| -46% | -$57.7K | 0.01% | 793 |
|
|
2018
Q4 | $82K | Buy |
1,469
+556
| +61% | +$31K | 0.01% | 689 |
|
|
2018
Q3 | $75K | Buy |
+913
| New | +$75K | 0.01% | 700 |
|
|
2018
Q1 | – | Sell |
-53
| Closed | -$2K | – | 1791 |
|
|
2017
Q4 | $2K | Hold |
53
| – | – | ﹤0.01% | 1519 |
|
|
2017
Q3 | $2K | Buy |
+53
| New | +$2K | ﹤0.01% | 1496 |
|
|
2017
Q2 | – | Sell |
-30
| Closed | -$1K | – | 1938 |
|
|
2017
Q1 | $1K | Buy |
+30
| New | +$1K | ﹤0.01% | 1579 |
|